Viewing nowCres Tablet 20mg (Rosuvastatin Calcium)
Rosuvastatin Calcium 20.8mg
Tablet · Prescription medication
Allico Pharmaceuticals Co., Ltd.

MFDS item code 201505163 · Approved 2015.07.30 · Insurance code 656003940
Treatment of hypercholesterolemia (primary, familial) and reduction of cardiovascular disease risk
This drug is used as an adjunct when diet and exercise are insufficient in patients with primary hypercholesterolemia and mixed dyslipidemia. It is also used with dietary therapy or other lipid-lowering therapy in patients with homozygous familial hypercholesterolemia to lower blood cholesterol levels and delay the progression of atherosclerosis, improving cardiovascular health. It is effective in reducing total cholesterol and LDL-cholesterol levels when added to the dietary therapy in pediatric patients aged 10 to 17 years with familial hypercholesterolemia. It is also utilized as an adjunct to diet in patients with primary dysbetalipoproteinemia. In particular, it helps reduce the risk of stroke, myocardial infarction, and arterial revascularization in middle-aged patients with elevated high-sensitivity C-reactive protein and additional risk factors for cardiovascular disease. Overall, this medication is used for the treatment of various types of hypercholesterolemia and to reduce the risk of cardiovascular disease.
The initial dose is 5 milligrams once daily; the maintenance dose can be adjusted if greater reductions in LDL cholesterol levels are required. The maintenance dose is typically 10 milligrams once daily, which is sufficient for most patients. Maintenance doses should be adjusted suitably every 4 weeks or more based on LDL cholesterol levels, treatment goals, and patient response, and can be increased to a maximum of 20 milligrams per day.
The usual dosage range for pediatric patients with heterozygous familial hypercholesterolemia (ages 10 to 17 years) is 5 milligrams to 20 milligrams once daily. The dosage should be adjusted according to the recommended treatment goals for each individual patient.
This drug should not be used in certain patients. For example, avoid administering this drug to patients with an allergy to it, severely impaired liver function, muscular disorders, significantly reduced kidney function, women who are pregnant or breastfeeding, and those taking specific medications. Additionally, patients should receive regular liver function tests and muscle-related tests before and during treatment. Caution is needed for patients with a history of alcohol consumption or liver disease. If symptoms such as myalgia or muscle weakness occur, consult a physician immediately. Since this drug may affect the liver and kidneys, patients with liver or kidney disease should use it more cautiously, and elderly patients or those with certain genetic predispositions should also exercise caution. Furthermore, this drug may interact with other medications, so any other medications being taken must be disclosed to healthcare professionals. The risk of muscle adverse reactions may increase when used with certain antivirals, antifungals, antibiotics, immunosuppressants, and lipid-lowering agents. Women with potential for pregnancy should use appropriate contraception while taking this medication, and it should be discontinued immediately if pregnancy is confirmed. It is also safer for breastfeeding women not to use this drug. In case of overdose, as there is no specific antidote, immediate appropriate treatment at a hospital is required, and liver function and muscle enzyme levels must be monitored. Finally, if symptoms such as dizziness or myalgia occur during this drug's use, caution should be taken when driving or operating machinery, and if an adverse reaction is suspected, consulting healthcare professionals immediately is essential.
Hypersensitivity reaction including urticaria and angioedema, Stevens-Johnson syndrome, drug reaction with eosinophilia and systemic symptoms (DRESS), rhabdomyolysis, immune-mediated necrotizing myopathy, jaundice, hepatitis, severe muscle weakness, dyspnea, severe edema, acute renal failure, oliguria, severe allergic reactions, severe skin reactions, respiratory issues, liver abnormalities (jaundice), severe neurological symptoms, severe edema or
Not everyone experiences these, and they can vary from person to person.
This medication may be sensitive to air or moisture, so it should be stored in a tightly closed container. The storage temperature should be maintained between 1 and 30 degrees Celsius at room temperature. This will help to retain the drug's effectiveness longer.
Pink round film-coated tablet
30 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowRosuvastatin Calcium 20.8mg
Tablet · Prescription medication
Allico Pharmaceuticals Co., Ltd.

Rosuvastatin Calcium 10.4mg
Tablet · Prescription medication
AstraZeneca Korea Co., Ltd.

Rosuvastatin Calcium 20.8mg
Tablet · Prescription medication
AstraZeneca Korea Co., Ltd.

Rosuvastatin Calcium 5.2mg
Tablet · Prescription medication
AstraZeneca Korea Co., Ltd.

Rosuvastatin Calcium 10.4mg
Tablet · Prescription medication
Chong Kun Dang Pharmaceutical Corp.

Rosuvastatin Calcium 10.4mg
Tablet · Prescription medication
Dong Gu Bio Pharmaceutical Co., Ltd.

Rosuvastatin Calcium 10.4mg
Tablet · Prescription medication
Boryung Pharmaceutical Co., Ltd.

Rosuvastatin Calcium 20.8mg
Tablet · Prescription medication
Jongkundang Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.